Berlin - Delayed Quote EUR

Carl Zeiss Meditec AG (AFX.BE)

44.50

-0.66

(-1.46%)

As of 11:44:03 AM GMT+1. Market Open.

$ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow$

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required). The ZEISS MEL 90 fully integrates into the Corneal Refractive Workflow to offer U.S. surgeons a fast, reliable, and streamlined surgery experience, complementing t

PR Newswire yesterday

CZMWF

CZMWY
-2.55%
An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 41% Undervalued

Key Insights The projected fair value for Carl Zeiss Meditec is €77.77 based on 2 Stage Free Cash Flow to Equity Carl...

Simply Wall St. 15 days ago

CZMWF

CZMWY
-2.55%
Carl Zeiss Meditec AG Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next

There's been a notable change in appetite for Carl Zeiss Meditec AG ( ETR:AFX ) shares in the week since its yearly...

Simply Wall St. last month

CZMWF

CZMWY
-2.55%
Carl Zeiss Meditec Full Year 2024 Earnings: EPS Beats Expectations

Carl Zeiss Meditec ( ETR:AFX ) Full Year 2024 Results Key Financial Results Revenue: €2.07b (down 1.1% from FY 2023...

Simply Wall St. last month

CZMWF

CZMWY
-2.55%
Carl Zeiss Meditec AG (CZMWF) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...

Despite a challenging fiscal year, Carl Zeiss Meditec AG (CZMWF) leverages new product launches and strategic market positioning to drive future growth.

GuruFocus.com last month

CZMWY
-2.55%
German company Zeiss opens global capability centre in India

The company aims to double its workforce in India to 5,000 within three years.

Verdict 2 months ago

CZMWY
-2.55%
Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...

Simply Wall St. 2 months ago

CZMWF

CZMWY
-2.55%
Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the...

Simply Wall St. 3 months ago

CZMWF

CZMWY
-2.55%
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS Medical Technology will showcase digital enhancements and revolutionary surgical solutions at the American Academy of Ophthalmology (AAO) conference from Oct. 19-21, 2024, in Chicago. These innovations across cataract, corneal refractive, retina, and glaucoma workflows, offer new, enhanced paths to patient management and treatment, using a digitally connected environment to help advance the clinical workflow to support a higher level of personalized care.

CNW Group 3 months ago

CZMWF

CZMWY
-2.55%
ZEISS introduces its latest Robotic Visualisation System for neuro surgery

At this year's Congress of Neurological Surgeons (CNS) in Houston, Texas, USA, ZEISS Medical Technology launches the KINEVO® 900 S. The latest Robotic Visualization System® is a further development of the successful ZEISS KINEVO 900 platform. With best digital visualization, collaborative assistant functions and connected intelligence, ZEISS KINEVO 900 S offers more clarity for complex surgical procedures in neurosurgery and other surgical disciplines.

PR Newswire 3 months ago

CZMWF

CZMWY
-2.55%
What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it led the XTRA gainers with a relatively...

Simply Wall St. 3 months ago

CZMWF

CZMWY
-2.55%
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.

ZEISS Medical Technology today announced the broad U.S. distribution of the MICOR® 700 from ZEISS, reinventing lens extraction with the first hand-held lens removal device with ultrasound-free operation, providing a sustainable solution with a low initial investment to help surgeons broaden their intraocular working space. Creating a gentler patient experience, the ZEISS MICOR 700 offers a revolutionary approach to lens removal, including patented crystalline lens extraction technology, a blunt

CNW Group 3 months ago

CZMWF

CZMWY
-2.55%
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

ZEISS Medical Technology will showcase digital innovations and its latest 3D visualization technology as part of the ZEISS Retina Workflow at the European Society of Retina Specialists (EURETINA) conference. The new solutions within the ZEISS Medical Ecosystem help improve the diagnosis and treatment of retinal patients using the latest integrated, digital technologies.

PR Newswire 4 months ago

CZMWF

CZMWY
-2.55%
The three-year loss for Carl Zeiss Meditec (ETR:AFX) shareholders likely driven by its shrinking earnings

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term Carl...

Simply Wall St. 4 months ago

CZMWF

CZMWY
-2.55%
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions

ZEISS Medical Technology will showcase its latest cataract and corneal refractive workflow innovations at the European Society of Cataract and Refractive Surgeons (ESCRS) conference. ZEISS leads the industry as the first medical device manufacturer to offer treatment for hyperopia with lenticule extraction using SMILE® pro in the CE markets. ZEISS is also celebrating its latest refractive milestone of surpassing the 10 million mark for lenticule extraction procedures performed with ZEISS SMILE a

PR Newswire 4 months ago

CZMWF

CZMWY
-2.55%
Private companies account for 59% of Carl Zeiss Meditec AG's (ETR:AFX) ownership, while institutions account for 22%

Key Insights The considerable ownership by private companies in Carl Zeiss Meditec indicates that they collectively...

Simply Wall St. 5 months ago

CZMWF

CZMWY
-2.55%
An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 37% Undervalued

Key Insights Carl Zeiss Meditec's estimated fair value is €99.47 based on 2 Stage Free Cash Flow to Equity Current...

Simply Wall St. 5 months ago

CZMWF

CZMWY
-2.55%
ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and data-driven workflow for ophthalmologists, supported by the largest OCT (optical coherence tomography) reference database in the U.S. market, as well as newly enhanced cybersecurity features. As part of the ZEISS Medical Ecosystem, the latest OCT device from ZEISS, which recently received clearance by the U.S. Food and Drug Administration (FDA), helps support informed, data-driven patient

PR Newswire 7 months ago

CZMWF

CZMWY
-2.55%
Returns At Carl Zeiss Meditec (ETR:AFX) Appear To Be Weighed Down

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

Simply Wall St. 7 months ago

CZMWF

CZMWY
-2.55%
Carl Zeiss Meditec Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Carl Zeiss Meditec ( ETR:AFX ) Second Quarter 2024 Results Key Financial Results Revenue: €472.1m (down 6.4% from 2Q...

Simply Wall St. 8 months ago

CZMWF

CZMWY
-2.55%

Performance Overview

Return	AFX.BE	DAX P
YTD	-3.18%	+2.55%
1-Year	-56.47%	+22.22%
3-Year	-69.30%	+28.54%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Carl Zeiss Meditec AG (AFX.BE)

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 41% Undervalued

Carl Zeiss Meditec AG Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next

Carl Zeiss Meditec Full Year 2024 Earnings: EPS Beats Expectations

Carl Zeiss Meditec AG (CZMWF) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...

German company Zeiss opens global capability centre in India

Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around

Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS introduces its latest Robotic Visualisation System for neuro surgery

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.

ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

The three-year loss for Carl Zeiss Meditec (ETR:AFX) shareholders likely driven by its shrinking earnings

ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions

Private companies account for 59% of Carl Zeiss Meditec AG's (ETR:AFX) ownership, while institutions account for 22%

An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 37% Undervalued

ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

Returns At Carl Zeiss Meditec (ETR:AFX) Appear To Be Weighed Down

Carl Zeiss Meditec Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Performance Overview